Zobrazeno 1 - 10
of 47
pro vyhledávání: '"R. Fabbris"'
Publikováno v:
British Journal of Cancer
The potential use of tumour-specific T-lymphocytes loaded with ricin in cell targeting experiments was investigated. Moloney-murine sarcoma virus (M-MSV)-specific T-lymphocytes, obtained in mass mixed leucocyte-tumour cell culture (MLTC) and a M-MSV-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce4a0c2ec2e8dadf985c3458838d4345
https://ora.ox.ac.uk/objects/uuid:c06fc59a-5497-4dd6-bdf1-3c7bbc8c451b
https://ora.ox.ac.uk/objects/uuid:c06fc59a-5497-4dd6-bdf1-3c7bbc8c451b
Publikováno v:
Medical Physics. 37:6310-6316
Purpose: Virtual Wedges™ were introduced in Siemens LINACs to improve the treatment workflow. The aim of the present work is the validation of dose calculation by MasterPlan-Oncentra treatment planning system for virtual wedged beams. Methods: The
Publikováno v:
Medical physics. 37(12)
Virtual Wedges were introduced in Siemens LINACs to improve the treatment workflow. The aim of the present work is the validation of dose calculation by MasterPlan-Oncentra treatment planning system for virtual wedged beams.The Oncor Siemens accelera
Autor:
R, Fabbris
Publikováno v:
Annali di igiene : medicina preventiva e di comunita. 13(4 Suppl 4)
Publikováno v:
Radiotherapy and Oncology. 37:S49
Publikováno v:
Radiotherapy and Oncology. 37:S50
Publikováno v:
Radiotherapy and Oncology. 37:S64
Autor:
R. Fabbris
Publikováno v:
Urologia Journal. 54:41-47
Autor:
G, Pizzi, S, Maluta, C, Polico, F, Calzavara, L, Loreggian, R, Fabbris, C, Cauzzo, O, Nibale, P, Francescon
Publikováno v:
La Radiologia medica. 67(10)
The authors examine 62 cases of curietherapy in the deep vagina on 21 cases of utero-vaginal applications and make a comparison between two dosimetric methods used to measure the dose to the rectum and to the bladder: the direct measure by the Siemen
Publikováno v:
La Radiologia medica. 73(6)
Personal experience is outlined with a preparative regimen consisting of total nodal irradiation (TNI) and cyclophosphamide in patients with severe aplastic anemia undergoing bone marrow transplantation (BMT). Nine patients (median age 23) previously